Letícia Sanguinetti Czepielewski1,2, Lei Wang3, Clarissa S Gama2, Deanna M Barch1,4. 1. Department of Psychological and Brain Sciences, Washington University in St Louis, St Louis, MO, USA. 2. Laboratório de Psiquiatria Molecular, Hospital de Clínicas de Porto Alegre, Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. 3. Departments of Psychiatry and Behavioral Sciences, Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Departments of Psychiatry and Radiology, Washington University in St Louis, St Louis, MO, USA.
Abstract
Background: Schizophrenia (SZ) is often characterized by cognitive and intellectual impairment. However, there is much heterogeneity across individuals, suggesting different trajectories of the illness. Recent findings have shown brain volume differences across subgroups of individuals with psychosis (SZ and bipolar disorder), such that those with intellectual and cognitive impairments presented evidence of early cerebral disruption, while those with cognitive but not intellectual impairments showed evidence of progressive brain abnormalities. Our aim was to investigate the relations of cognition and intellectual functioning with brain structure abnormalities in a sample of SZ compared to unaffected individuals. Methods: 92 individuals with SZ and 94 healthy controls part of the Northwestern University Schizophrenia Data and Software Tool (NUSDAST) underwent neuropsychological assessment and structural magnetic resonance imaging (MRI). Individuals with SZ were divided into subgroups according their estimated premorbid crystallized intellectual (ePMC-IQ) and cognitive performance. Brain volumes differences were investigated across groups. Results: SZ with ePMC-IQ and cognitive impairments had reduced total brain volume (TBV), intracranial volume (ICV), TBV corrected for ICV, and cortical gray matter volume, as well as reduced cortical thickness, and insula volumes. SZ with cognitive impairment but intact ePMC-IQ showed only reduced cortical gray matter volume and cortical thickness. Conclusions: These data provide additional evidence for heterogeneity in SZ. Impairments in cognition associated with reduced ePMC-IQ were related to evidence of broad brain structural alterations, including suggestion of early cerebral disruption. In contrast, impaired cognitive functioning in the context of more intact intellectual functioning was associated with cortical alterations that may reflect neurodegeneration.
Background: Schizophrenia (SZ) is often characterized by cognitive and intellectual impairment. However, there is much heterogeneity across individuals, suggesting different trajectories of the illness. Recent findings have shown brain volume differences across subgroups of individuals with psychosis (SZ and bipolar disorder), such that those with intellectual and cognitive impairments presented evidence of early cerebral disruption, while those with cognitive but not intellectual impairments showed evidence of progressive brain abnormalities. Our aim was to investigate the relations of cognition and intellectual functioning with brain structure abnormalities in a sample of SZ compared to unaffected individuals. Methods: 92 individuals with SZ and 94 healthy controls part of the Northwestern University Schizophrenia Data and Software Tool (NUSDAST) underwent neuropsychological assessment and structural magnetic resonance imaging (MRI). Individuals with SZ were divided into subgroups according their estimated premorbid crystallized intellectual (ePMC-IQ) and cognitive performance. Brain volumes differences were investigated across groups. Results: SZ with ePMC-IQ and cognitive impairments had reduced total brain volume (TBV), intracranial volume (ICV), TBV corrected for ICV, and cortical gray matter volume, as well as reduced cortical thickness, and insula volumes. SZ with cognitive impairment but intact ePMC-IQ showed only reduced cortical gray matter volume and cortical thickness. Conclusions: These data provide additional evidence for heterogeneity in SZ. Impairments in cognition associated with reduced ePMC-IQ were related to evidence of broad brain structural alterations, including suggestion of early cerebral disruption. In contrast, impaired cognitive functioning in the context of more intact intellectual functioning was associated with cortical alterations that may reflect neurodegeneration.
Authors: Cecilie Bhandari Hartberg; Glenn Lawyer; Håkan Nyman; Erik G Jönsson; Unn K Haukvik; Peter Saetre; Petr S Bjerkan; Ole A Andreassen; Håkan Hall; Ingrid Agartz Journal: Psychiatry Res Date: 2010-04-24 Impact factor: 3.222
Authors: Anne-Kathrin J Fett; Wolfgang Viechtbauer; Maria-de-Gracia Dominguez; David L Penn; Jim van Os; Lydia Krabbendam Journal: Neurosci Biobehav Rev Date: 2010-07-08 Impact factor: 8.989
Authors: Madeleine Goodkind; Simon B Eickhoff; Desmond J Oathes; Ying Jiang; Andrew Chang; Laura B Jones-Hagata; Brissa N Ortega; Yevgeniya V Zaiko; Erika L Roach; Mayuresh S Korgaonkar; Stuart M Grieve; Isaac Galatzer-Levy; Peter T Fox; Amit Etkin Journal: JAMA Psychiatry Date: 2015-04 Impact factor: 21.596
Authors: Margo W Menkes; Kristan Armstrong; Jennifer Urbano Blackford; Stephan Heckers; Neil D Woodward Journal: Schizophr Res Date: 2018-10-26 Impact factor: 4.939
Authors: Alexandra B Moussa-Tooks; Baxter P Rogers; Anna S Huang; Julia M Sheffield; Stephan Heckers; Neil D Woodward Journal: Biol Psychiatry Date: 2022-03-28 Impact factor: 12.810
Authors: A M Sánchez-Torres; L Moreno-Izco; R Lorente-Omeñaca; B Cabrera; A Lobo; A M González-Pinto; J Merchán-Naranjo; I Corripio; E Vieta; E de la Serna; A Butjosa; F Contreras; S Sarró; G Mezquida; M Ribeiro; M Bernardo; M J Cuesta Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-11-21 Impact factor: 5.270
Authors: Tamsyn E Van Rheenen; Vanessa Cropley; Andrew Zalesky; Chad Bousman; Ruth Wells; Jason Bruggemann; Suresh Sundram; Danielle Weinberg; Roshel K Lenroot; Avril Pereira; Cynthia Shannon Weickert; Thomas W Weickert; Christos Pantelis Journal: Schizophr Bull Date: 2018-04-06 Impact factor: 9.306
Authors: Anthony O Ahmed; Samantha Kramer; Naama Hofman; John Flynn; Marie Hansen; Victoria Martin; Anilkumar Pillai; Peter F Buckley Journal: Neuropsychobiology Date: 2021-03-11 Impact factor: 2.328
Authors: R Walter Heinrichs; Farena Pinnock; Melissa Parlar; Colin Hawco; Lindsay Hanford; Geoffrey B Hall Journal: Schizophr Res Treatment Date: 2017-02-28
Authors: New Fei Ho; Benjamin J H Lee; Jordon X J Tng; Max Z Y Lam; Guoyang Chen; Mingyuan Wang; Juan Zhou; Richard S E Keefe; Kang Sim Journal: Eur Psychiatry Date: 2020-04-27 Impact factor: 5.361